We are live on
!
Find out more
Impax Asset Management Group Portfolio holdings
AUM
$15.4B
1-Year Est. Return
26.43%
This Fund
S&P 500
This Quarter
Est. Return
+7.66%
1 Year Est. Return
+26.43%
3 Year Est. Return
+65.67%
5 Year Est. Return
+80.61%
10 Year Est. Return
–
AUM
$22.7B
AUM Growth
+$3.13B
(+16%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
7.37%
Top 10 Holdings %
Top 10 Hldgs %
29.44%
Holding
418
New
17
Increased
136
Reduced
146
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$139M |
| 2 |
Ecolab
ECL
|
+$134M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$90.2M |
| 4 |
Herc Holdings
HRI
|
+$88.7M |
| 5 |
Linde
LIN
|
+$80.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$93M |
| 2 |
Franklin Electric
FELE
|
+$79.1M |
| 3 |
Rayonier
RYN
|
+$61M |
| 4 |
Generac Holdings
GNRC
|
+$34.7M |
| 5 |
GRFS
Grifois
GRFS
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 30.77% |
| 2 | Technology | 22.72% |
| 3 | Healthcare | 14.2% |
| 4 | Materials | 6.86% |
| 5 | Utilities | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ligand Pharmaceuticals
LGND
$5.76B
| $10.4M | 0.05% |
127,150
-8,161
| -6% | -$679K |
|
152
8x8 Inc
EGHT
$303M
| $10.4M | 0.05% |
373,491
+153,491
| +70% | +$4.35M |
|
153
Pacira BioSciences
PCRX
$924M
| $10.3M | 0.05% |
170,027
+45,027
| +36% | +$2.85M |
|
154
Bank of America
BAC
$448B
| $10.3M | 0.05% |
248,670
-217
| -0.1% | -$8.89K |
|
155
QuinStreet
QNST
$1.19B
| $10.2M | 0.05% |
551,390
+282,121
| +105% | +$5.35M |
|
156
Walt Disney
DIS
$181B
| $10.2M | 0.05% |
58,245
-23
| -0% | -$4.14K |
|
|
VCRA
157
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $10.2M | 0.05% |
256,724
+110,241
| +75% | +$4.02M |
|
158
Ciena
CIEN
$62.7B
| $10.1M | 0.04% |
178,064
+33,935
| +24% | +$1.87M |
|
159
Cisco
CSCO
$447B
| $10.1M | 0.04% |
190,320
-415
| -0.2% | -$21.8K |
|
160
Element Solutions
ESI
$9.51B
| $9.98M | 0.04% |
426,946
+27,455
| +7% | +$604K |
|
161
Extreme Networks
EXTR
$3.16B
| $9.6M | 0.04% |
859,781
-140,219
| -14% | -$1.49M |
|
162
NVIDIA
NVDA
$5.46T
| $9.59M | 0.04% |
479,480
| – | – |
|
163
Leslie's
LESL
$7.21M
| $9.51M | 0.04% |
+17,301
| New | +$9.49M |
|
164
Eli Lilly
LLY
$1.08T
| $9.46M | 0.04% |
41,200
-4
| -0% | -$803 |
|
165
Simply Good Foods
SMPL
$989M
| $9.44M | 0.04% |
258,620
+138,620
| +116% | +$4.74M |
|
166
Quanex
NX
$981M
| $9.29M | 0.04% |
373,986
+73,986
| +25% | +$1.97M |
|
167
AbbVie
ABBV
$443B
| $8.98M | 0.04% |
79,713
+5
| +0% | +$563 |
|
168
Planet Fitness
PLNT
$3.71B
| $8.86M | 0.04% |
117,742
+24,271
| +26% | +$1.93M |
|
169
Emerson Electric
EMR
$91.6B
| $8.65M | 0.04% |
89,871
+50,612
| +129% | +$4.76M |
|
|
KRTX
170
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $8.49M | 0.04% |
74,463
+5,456
| +8% | +$638K |
|
171
Verra Mobility
VRRM
$731M
| $8.43M | 0.04% |
+548,661
| New | +$7.96M |
|
172
Columbia Sportswear
COLM
$2.96B
| $8.41M | 0.04% |
85,515
+5,813
| +7% | +$609K |
|
173
Elevance Health
ELV
$86.4B
| $8.35M | 0.04% |
21,876
+4,195
| +24% | +$1.6M |
|
174
Comfort Systems
FIX
$60.8B
| $8.33M | 0.04% |
105,695
-7,533
| -7% | -$614K |
|
175
Zoetis
ZTS
$31.3B
| $8.28M | 0.04% |
44,412
-4
| -0% | -$695 |
|
Similar funds
UM
NMO
EH
IA
AT
EF
MG
Impax Asset Management Group's Q2 2021 Portfolio in Review
As of Q2 2021, Impax Asset Management Group held 418 positions worth $22.7B, up 16% from $19.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Impax Asset Management Group deployed $1.67B of net new capital in Q2 2021, opening 17 new positions and adding to 136 existing holdings. Its largest new stake was Stericycle Inc: 1,226,874 shares worth $87M.
By sector, the portfolio is most concentrated in Industrials at 31% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $93M trimmed.
- Impax Asset Management Group's largest Q2 2021 buy was Stericycle Inc: 1,226,874 shares worth $87M.
- Impax Asset Management Group added most to Vertex Pharmaceuticals in Q2 2021, an estimated $139M increase.
- Impax Asset Management Group's biggest Q2 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $93M.
- Impax Asset Management Group fully exited Cigna in Q2 2021, selling an estimated $18M.
- Impax Asset Management Group's ten largest holdings make up 29% of its $22.7B portfolio in Q2 2021.
- Impax Asset Management Group opened 17 new positions and closed 14 in Q2 2021.
- Impax Asset Management Group's portfolio value rose 16% quarter-over-quarter to $22.7B.
Based on Impax Asset Management Group's 13F filing for Q2 2021, filed 5 Aug 2021.